NASDAQ · Healthcare · Biotechnology
Outlook Therapeutics, Inc.
OTLK
Outlook Therapeutics, Inc. CEO Robert Charles Jahr · Market cap $71.2M.
$1.73
+0.12 · +7.45%
52w hi $3.3952w lo $0.16
Off 52w high 82.7%
75
STRONG
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
1 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $1.00
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 27 | Faisal Ghiath Sukhtian | Buy | 122,174 | $0.41 | +$50K | 72 | |
| May 26 | Kurt J Hilzinger | Buy | 400,000 | $0.44 | +$177K | 75 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun